aTyr Pharma, Inc.
aTyr Pharma develops biologics derived from tRNA synthetase domains for fibrosis and inflammation.
8-KSep 24Latest SEC filing, period to Sep 24
Aug 7Latest story
August 2026
July 2026
Sign inSign inaTyr Pharma develops biologics derived from tRNA synthetase domains for fibrosis and inflammation.